Search results for:

desmopressin

desmopressin
Brand names: DDAVP
Form Strength
SOLUTION, INJECTABLE 4 mcg/mL
SPRAY, NASAL 10 mcg/spray
TABLET, ORAL 0.2 mg
Display Pituitary Class: 682800
Medication comments:

Refrigerator item 

2023 American Geriatrics Society Beers Criteria® for potentially inappropriate medication use in older adults.
Medication: desmopressin (DDAVP)
Criteria 1: Potentially inappropriate medication use in older adults. (Table 2)
Drug(s) desmopressin
Rationale High risk of hyponatremia; safer alternative treatments for nocturia (including nonpharmacologic).
Recommendation Avoid for treatment of nocturia or nocturnal polyuria.
 Quality of evidence: Moderate, Strength of Recommendation: Strong
Last updated: Sep. 18, 2025
  • Look-Alike/Sound-Alike desmopressin confused with vasopressin
UpToDate Lexidrug

Pharmacy Contact Info:

Main Inpatient Pharmacy: ext 4599, 3503
Fax: 704-878-7283

Director of Pharmacy - Randi Raynor, PharmD: ext 4501
Clinical Coordinator - Laura Rollings, PharmD: ext 4597
Pharmacy Informaticist - Stephen Pringle, PharmD: ext 7645
Pharmacy Technician Supervisor - Amy Wingler, CPhT: ext 7385
Pharmacy Automation Coordinator (Omnicell) - Melissa Fulford, CPhT: ext 3556



This site is intended for the staff of Iredell Health System. While others may view accessible pages, Iredell Health System makes no warranty, express or implied, as to the use of this information outside of Iredell Health System. The content of this policy and procedure document serves as guidance to the delivery of quality patient care. Care providers are expected to exercise critical thinking and situational awareness skills, and in specific situations to take such action as is necessary for the delivery of quality patient care.
Copyright © 2025 Rpharmy, LLC ­ All Rights Reserved